Stocks and Investing Stocks and Investing
Thu, May 2, 2024

Gil Blum Reiterated (TSHA) at Strong Buy and Held Target at $7 on, May 2nd, 2024


Published on 2024-10-28 10:53:58 - WOPRAI, Gil Blum
  Print publication without navigation


Gil Blum of Needham, Reiterated "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $7 on, May 2nd, 2024.

Gil has made no other calls on TSHA in the last 4 months.



There are 5 other peers that have a rating on TSHA. Out of the 5 peers that are also analyzing TSHA, 0 agree with Gil's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Gil


  • Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $7 on, Tuesday, April 30th, 2024
  • Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $9 on, Tuesday, April 9th, 2024
  • Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Increased Target to $7 on, Thursday, March 21st, 2024
  • Whitney Ijem of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $7 on, Thursday, March 21st, 2024
  • Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $5 on, Wednesday, March 20th, 2024

Contributing Sources